{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T19:58:24Z","timestamp":1649188704600},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1684\/bdc.2012.1552","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T20:01:59Z","timestamp":1565726519000},"page":"417-423","source":"Crossref","is-referenced-by-count":1,"title":["Quelle prise en charge pour les hommes asymptomatiques, porteurs d\u2019une mutation du g\u00e8ne BRCA1 ou 2 ? R\u00e9sultat d\u2019une enqu\u00eate de pratique aupr\u00e8s des centres d\u2019oncog\u00e9n\u00e9tique fran\u00e7ais"],"prefix":"10.1016","volume":"99","author":[{"given":"Iglika","family":"Brachot-Simeonova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Morin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Gillaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Demeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Gondry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mich\u00e8le","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffa\u00e8le","family":"Fauvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2012.1552_bib0005","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2012.1552_bib0010","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2012.1552_bib0015","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.patbio.2006.02.002","article-title":"Identification et prise en charge des pr\u00e9dispositions h\u00e9r\u00e9ditaires aux cancers du sein et de l\u2019ovaire (mise \u00e0 jour 2004)","volume":"54","author":"Eisinger","year":"2006","journal-title":"Pathol Biol (Paris)"},{"key":"10.1684\/bdc.2012.1552_bib0020","unstructured":"INCa. Principales recommandations de prise en charge des femmes porteuses d\u2019une mutation BRCA1 ou BRCA2. 2009 (www.e-cancer.fr)."},{"key":"10.1684\/bdc.2012.1552_bib0025","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/jnci\/djm203","article-title":"Breast cancer risk among male BRCA1 and BRCA2 mutation carriers","volume":"99","author":"Tai","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2012.1552_bib0030","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.breast.2008.05.001","article-title":"Counseling for male BRCA mutation carriers: a review","volume":"17","author":"Mohamad","year":"2008","journal-title":"Breast"},{"key":"10.1684\/bdc.2012.1552_bib0035","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1552_bib0040","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/316907","article-title":"Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling","volume":"67","author":"Liede","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1684\/bdc.2012.1552_bib0045","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1684\/bdc.2012.1552_bib0050","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2012.1552_bib0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1086\/513891","article-title":"Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13","volume":"61","author":"Easton","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1684\/bdc.2012.1552_bib0060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1442-2042.2006.01712.x","article-title":"BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families","volume":"14","author":"Azzouzi","year":"2007","journal-title":"Int J Urol"},{"key":"10.1684\/bdc.2012.1552_bib0065","first-page":"209","article-title":"D\u00e9pistage du cancer de la prostate","volume":"13","author":"Villers","year":"2003","journal-title":"Prog Urol"},{"key":"10.1684\/bdc.2012.1552_bib0070","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0022-5347(05)64541-7","article-title":"Hereditary prostate cancer: clinical aspects","volume":"168","author":"Bratt","year":"2002","journal-title":"J Urol"},{"key":"10.1684\/bdc.2012.1552_bib0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1464-410X.2010.09648.x","article-title":"Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study","volume":"107","author":"Mitra","year":"2011","journal-title":"BJU Int"},{"key":"10.1684\/bdc.2012.1552_bib0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3322\/canjclin.53.1.27","article-title":"American Cancer Society guidelines for the early detection of cancer, 2003","volume":"53","author":"Smith","year":"2003","journal-title":"CA Cancer J Clin"},{"key":"10.1684\/bdc.2012.1552_bib0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3322\/caac.20066","article-title":"American Cancer Society guideline for the early detection of prostate cancer: update 2010","volume":"60","author":"Wolf","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1684\/bdc.2012.1552_bib0090","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1073\/pnas.89.8.3367","article-title":"Mendelian inheritance of familial prostate cancer","volume":"89","author":"Carter","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1684\/bdc.2012.1552_bib0095","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jmg.2009.075176","article-title":"Risk of breast cancer in male BRCA2 carriers","volume":"47","author":"Evans","year":"2010","journal-title":"J Med Genet"},{"key":"10.1684\/bdc.2012.1552_bib0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.20312","article-title":"Breast carcinoma in men: a population-based study","volume":"101","author":"Giordano","year":"2004","journal-title":"Cancer"},{"key":"10.1684\/bdc.2012.1552_bib0105","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/bcr419","article-title":"BRCA1 and BRCA2 mutations in a population-based study of male breast cancer","volume":"4","author":"Basham","year":"2002","journal-title":"Breast Cancer Res"},{"key":"10.1684\/bdc.2012.1552_bib0110","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3892\/or_00000962","article-title":"Male breast cancer: risk factors, diagnosis, and management","volume":"24","author":"Johansen Taber","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1684\/bdc.2012.1552_bib0115","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","article-title":"Estimates of cancer incidence and mortality in Europe in 2008","volume":"46","author":"Ferlay","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1684\/bdc.2012.1552_bib0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0011-3840(99)80805-3","article-title":"Pancreatic cancer","volume":"36","author":"Yeo","year":"1999","journal-title":"Curr Probl Surg"},{"key":"10.1684\/bdc.2012.1552_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940100309X","article-title":"BRCA2 and predisposition to pancreatic and other cancers","volume":"2001","author":"Arnold","year":"2001","journal-title":"Expert Rev Mol Med"},{"key":"10.1684\/bdc.2012.1552_bib0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1385\/IJGC:31:1-3:99","article-title":"BRCA2 and pancreatic cancer","volume":"31","author":"Naderi","year":"2002","journal-title":"Int J Gastrointest Cancer"},{"key":"10.1684\/bdc.2012.1552_bib0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.2008.18.5546","article-title":"BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma","volume":"27","author":"Ferrone","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1552_bib0140","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2012.1552_bib0145","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrc949","article-title":"Pancreatic cancer biology and genetics","volume":"2","author":"Bardeesy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1684\/bdc.2012.1552_bib0150","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0025-7125(05)70253-4","article-title":"Cancer surveillance of patients from familial pancreatic cancer kindreds","volume":"84","author":"Brentnall","year":"2000","journal-title":"Med Clin North Am"},{"key":"10.1684\/bdc.2012.1552_bib0155","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1053\/j.gastro.2010.08.012","article-title":"Hereditary pancreatic cancer","volume":"139","author":"Grover","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1684\/bdc.2012.1552_bib0160","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1684\/bdc.2011.1396","article-title":"Strat\u00e9gies de d\u00e9pistage de l\u2019ad\u00e9nocarcinome pancr\u00e9atique chez les patients \u00e0 haut risque","volume":"98","author":"Bechade","year":"2011","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2012.1552_bib0165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0025-7125(05)70241-8","article-title":"Genetic testing. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases","volume":"84","author":"Applebaum","year":"2000","journal-title":"Med Clin North Am"},{"key":"10.1684\/bdc.2012.1552_bib0170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bpg.2009.02.001","article-title":"Hereditary pancreatic cancer: a clinical perspective","volume":"23","author":"Greer","year":"2009","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1684\/bdc.2012.1552_bib0175","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1245\/ASO.2006.05.021","article-title":"Implication of the BRCA2 and putative BRCA3 \u201c\u201d genes in Dukes\u2019 stage C, replication error-negative colon cancer","volume":"13","author":"Sivarajasingham","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1684\/bdc.2012.1552_bib0180","first-page":"60","article-title":"BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian","volume":"7","author":"Friedenson","year":"2005","journal-title":"Med Gen Med"},{"key":"10.1684\/bdc.2012.1552_bib0185","first-page":"559","article-title":"Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study","volume":"20","author":"Drucker","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1684\/bdc.2012.1552_bib0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10689-008-9206-8","article-title":"Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin","volume":"8","author":"Kadouri","year":"2009","journal-title":"Fam Cancer"},{"key":"10.1684\/bdc.2012.1552_bib0195","doi-asserted-by":"crossref","first-page":"e4812","DOI":"10.1371\/journal.pone.0004812","article-title":"Potential excess mortality in BRCA1\/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma","volume":"4","author":"Mai","year":"2009","journal-title":"PLoS One"},{"key":"10.1684\/bdc.2012.1552_bib0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.gyobfe.2009.12.014","article-title":"Modalit\u00e9s de fonctionnement d\u2019un centre de suivi des femmes \u00e0 haut risque de cancer du sein et de l\u2019ovaire : une exp\u00e9rience \u00e0 l\u2019h\u00f4pital Tenon","volume":"38","author":"Chabbert-Buffet","year":"2010","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1684\/bdc.2012.1552_bib0205","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/01.cej.0000391570.71877.18","article-title":"Impact of general practitioners\u2019 sex and age on systematic recommendation for cancer screening","volume":"20","author":"Eisinger","year":"2011","journal-title":"Eur J Cancer Prev"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115304586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115304586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T17:20:07Z","timestamp":1610817607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115304586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0007455115304586"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2012.1552","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}